Press release
Tetanus Toxoid Vaccine Market 2018 Booming Cancer Industry by 5.3% CAGR till 2023 with Most Demanding Players - GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech
Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. The spasms may be very severe and even cause bone fractures. Other symptoms include fever, sweating, headache, trouble swallowing, hypertension etc. About 10% of those infected, die while a large number become incapacitated due to bone fractures.
Tetanus toxoid vaccine is an inactive vaccine used to prevent tetanus by developing immunity against the pathogen causing tetanus. The general dosage recommendation is five doses during childhood, with a sixth given during adolescence with additional doses every 10 years. The tetanus vaccine was initially developed in 1924 and has resulted in a 95% decrease in the rate of tetanus in the US and is on the World Health Organization's List of Essential Medicines. The vaccine also is considered very safe even during pregnancy and for those with HIV.
Get Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4024
The market restraints of the tetanus toxoid vaccine are redness and pain at the site of injection, fever, and fatigue and muscles pains. Severe allergic reactions are the most serious side effects of the Tetanus toxoid vaccine which occur in less than one in 100,000 people. The market for tetanus toxoid vaccine is bipolar with contractual market having a sizable number of share as compared to the private market. The other market constraints include falling profitability of vaccine manufacturing, huge reduction of tetanus in the developed world which effectively eliminates the need for further vaccination due to herd immunity, side effects associated with vaccines, variability of efficacy of tetanus toxoid vaccine etc.
Considering all these factors, the market for Tetanus toxoid vaccine is expected to reach $ 5.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 5.3 % during 2017-2023.
Global Tetanus Toxoid Vaccine Market -Segments
The global tetanus toxoid vaccine market is segmented on the basis of types, forms and end users. Based on types, the market has been segmented as monovalent tetanus toxoid (TT), diphtheria, tetanus, and pertussis (DTaP), diphtheria and tetanus (DT), tetanus, diphtheria, and pertussis (Tdap) and others. Based on the forms, the market has been segmented as quadrivalent, pentavalent, and hexavalent. Based on the end users, the market has been segmented as biotech and hospitals and clinics, government organizations, research and others.
Global Tetanus Toxoid Vaccine Market -Regional analysis
US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global Tetanus toxoid vaccine. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.
Obtain Report Details with TOC @ https://www.marketresearchfuture.com/reports/tetanus-toxoid-vaccine-market-4024
Global Tetanus Toxoid Vaccine Market -Key players
Key players profiled in the report are
GlaxoSmithKline Plc.,
Merck & Co. Inc.,
Pfizer, Inc.,
Sanofi Pasteur, Inc.,
AstraZeneca Plc.,
Bharat Biotech,
Shenzhen Kangtai Biological Products,
Valeant Pharmaceuticals,
Emergent Biosolutions Inc.,
Astellas Pharma Inc.,
Panacea Biotec
Global Tetanus Toxoid Vaccine -Major Points from TOC
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Tetanus Toxoid Vaccine Market, By Type
Chapter 7. Global Tetanus Toxoid Vaccine Market, By Treatment
Chapter 8 Global Tetanus Toxoid Vaccine Market, By End User
Chapter 9. Global Tetanus Toxoid Vaccine Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
Get Excusive Discount @ https://www.marketresearchfuture.com/check-discount/4024
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tetanus Toxoid Vaccine Market 2018 Booming Cancer Industry by 5.3% CAGR till 2023 with Most Demanding Players - GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech here
News-ID: 1166171 • Views: …
More Releases from Market Research Future
Subsea Manifolds Market Projection: USD 4,120.53 Million in 2025 Rising to USD 6 …
The subsea manifolds market plays a critical role in modern offshore oil and gas production by enabling efficient control, distribution, and monitoring of hydrocarbons on the seabed. Subsea manifolds act as gathering points that connect multiple wells to production systems, allowing operators to optimize flow management, reduce infrastructure complexity, and improve overall field performance. As offshore exploration moves into deeper waters and more technically challenging environments, subsea manifolds have become…
Military Cybersecurity Market 2026: Innovation, AI Defense, and Strategic Demand
In an era defined by rapidly evolving cyber threats and digital warfare, the Military Cybersecurity industry is undergoing a fundamental transformation. As nation-states, defense organizations, and allied forces expand their reliance on digital networks, unmanned systems, IoT-enabled platforms, and cloud infrastructures, securing military cyberspace has become a strategic priority. The shifting threat landscape is driving unprecedented demand for advanced cybersecurity solutions that can protect critical defense assets, ensure operational continuity,…
Drone Identification Market Thriving Worldwide industry with AI by 78.23 USD Bil …
The Drone Identification Market is gaining significant traction in 2026 as unmanned aerial systems (UAS) become more widespread across commercial, governmental, and recreational applications. With drone usage expanding rapidly, there is a pressing need for effective identification, tracking, and management systems that ensure airspace safety, regulatory compliance, and coordinated operations. This demand is driving investment in advanced technologies and solutions that support remote identification, situational awareness, and secure communications within…
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CA …
The Healthcare BPO (Business Process Outsourcing) Market is experiencing significant growth as healthcare providers increasingly outsource non-core functions to specialized service providers. Healthcare BPO services include medical billing and coding, claims processing, customer care, revenue cycle management, IT support, telehealth support, transcription services, and other administrative functions. Outsourcing enables healthcare organizations to reduce operational costs, improve process efficiency, and focus on core clinical services.
Market Overview and Growth Trends
As per Market…
More Releases for Tetanus
Tetanus Market Value Projected to Expand by 2029
Tetanus Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 21.36% from 2024 to 2030. Welcome to our comprehensive exploration of the Tetanus market, where we uncover the trends, innovations, and dynamics shaping the landscape of tetanus prevention and treatment. Tetanus, a potentially life-threatening bacterial infection, continues to pose challenges globally, driving the demand for effective preventive…
Diphtheria, Pertussis, and Tetanus Vaccine Market
According to a new report published by Allied Market Research, titled, "Diphtheria, Pertussis, and Tetanus Vaccine Market by Product Type [DTaP (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel), Td (Decavac and Tenivac), and Tdap (Boostrix and Adacel)], Vaccine Type (Whole-Cell Vaccine and Acellular Vaccine), Age Group (Adult and Pediatric), and End User (Hospitals, Clinics, and Vaccination Centers) - Global Opportunity and Forecast, 2019-2026 ".
The Global market size of Diphtheria, Pertussis,…
Tetanus Therapeutics- Pipeline Analysis 2018 | Zydus Group
Tetanus, also known as lockjaw is a bacterial disease caused by Clostridium tetani. The bacteria are usually found in dust, soil, and manure and enter the body through breaks in the skin. The spores develop into bacteria when they enter the body.
Download the sample report @ https://www.pharmaproff.com/request-sample/1074
These spores can get into the body through broken skin, usually through injuries from contaminated objects. Certain breaks in the skin are more…
Tetanus-Pipeline Review H2 2018
Tetanus (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various…
Tetanus-Pipeline Review H2 2018
Tetanus (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various…
Tetanus - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Tetanus - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tetanus - Pipeline Review, H1 2017, provides an overview of the Tetanus (Infectious Disease) pipeline landscape.
Tetanus is a serious illness caused by Clostridium bacteria. Signs and symptoms of tetanus include spasms and stiffness in jaw muscles,…
